Patient Support Programming in 2025 and Beyond
Your on-demand access to the recorded discussion is now available.
We may be confronting a perfect storm driven by three primary forces: destructive effects of the Inflation Reduction Act (IRA), legal/regulatory battles over copay adjustment programs, and uncertainties following a national election.
The 2024 Election, Inflation Reduction Act, and Copay Adjustment Programs
As we approach 2025, it’s crucial for manufacturers to take proactive steps to ensure resilient and responsive patient support programs.
Tune in as we examine the key forces likely to impact patient support programs (PSPs) in the coming year, including the steps manufacturers can take to ride out the storm and offer powerful programs despite these challenges.
Featuring a Conversation with:
.png?width=240&height=240&name=Dowd%20-%20Chris%202023%20(2).png)
.png?width=320&height=320&name=Dowd%20-%20Chris%202023%20(2).png)
SVP, Market Development, ConnectiveRx
In his more than 25-year career, Chris has become a recognized voice in the patient affordability and specialty medication arena, pioneering prominent copay and patient affordability programs, and creating innovative solutions for his clients.
A recognized leader in the space, Dowd has been on the forefront of virtually every development in the patient copay industry over the past decade.
Chris leads strategic market analysis and product go-to-market strategies at ConnectiveRx.
Vice President,
North Star Opinion Research
Jon McHenry is Vice President of North Star Opinion Research. In addition to working with the firm’s political, public affairs, and corporate clients, he oversees the firm’s fielding procedures and methodology.
Jon’s corporate and public affairs work has focused on health care, including work with Horizon Public Affairs, PCMA, and United Health Group; telecommunications, including AT&T as a client; transportation, working with both government and private firms; and employee satisfaction research, most notably with Georgia-Pacific.
Jon’s comments and analysis have appeared in a variety of media settings, including CBS, CNN, Fox News, NBC Nightly News, the Boston Globe, The Daily Caller, The Hill, The New York Times, and the Washington Post.
Health Policy Manager,
HIV + Hepatitis Policy Institute
Kevin Herwig is Health Policy Manager at HIV+Hepatitis Policy Institute, where he focuses on policy advocacy relating to access to PrEP and HIV and viral hepatitis treatment. He is a co-chair of the HIV Prevention Action Coalition workgroup of the Federal AIDS Policy Partnership, and serves on the Board of Directors of Community Resource Initiative in Boston. Before joining HIV+Hep in 2022, he managed the Massachusetts PrEP Drug Assistance Program.
Industry Smarts
Check out the latest from our team of industry veterans and service innovators here at ConnectiveRx.
- Awareness and Adherence
Pharma Messaging 2025: What's Hot, What's Next, and Why It Matters
Read MoreAre Your Patient Support Programs IRA Ready?
Hub and copay programs are likely to encounter complex payer tactics like benefit redesign and reduced plan availability. Our recent live event offers expert insights on navigating these challenges effectively.
